Back

Downregulation of acetyl-CoA carboxylase suppresses the malignant progression of oral cancer

jia, g.

2024-07-23 cancer biology
10.1101/2024.07.21.604509 bioRxiv
Show abstract

In this study, we aimed to investigate the specific role of the acetyl-CoA carboxylase (ACACA) gene in Oral squamous cell carcinoma (OSCC). we constructed Human Tongue Carcinoma Cell Line (SAS cell line) with low ACACA expression and evaluated changes in their cell cycle, proliferation, and metabolite levels. Furthermore, the effect of ACACA on tumor formation in vivo was determined. ACACA knockdown significantly reduced the proliferation ability of SAS cells, while also significantly increasing the number of apoptotic cells. In vivo experiments demonstrated lower tumor volume and weight in the ACACA knockdown group than those in the control group. Exploring the combined effect of ACACA knockdown and cisplatin treatment revealed a promising synergistic effect against ferroptosis signaling and downstream signaling pathways in SAS cells and in vivo. These findings suggest that targeting the ACACA gene has the potential to be a novel therapeutic strategy for oral cancer treatment.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
Cancers
○ 213 papers in training set
Top 0.1%
22.2%
Similar papers in this journal
2
PLOS ONE
● 5266 papers in training set
Top 25%
6.3%
Similar papers in this journal
3
Frontiers in Oncology
○ 103 papers in training set
Top 0.6%
5.2%
Similar papers in this journal
4
Scientific Reports
○ 3612 papers in training set
Top 31%
3.3%
Similar papers in this journal
5
Frontiers in Molecular Biosciences
○ 102 papers in training set
Top 0.2%
3.3%
6
Biochemistry and Biophysics Reports
○ 30 papers in training set
Top 0.1%
3.3%
Similar papers in this journal
7
Biomedicine & Pharmacotherapy
○ 42 papers in training set
Top 0.3%
3.2%
8
Acta Biochimica et Biophysica Sinica
● 23 papers in training set
Top 0.1%
2.8%
9
Heliyon
○ 152 papers in training set
Top 2%
2.7%
50% of probability mass above
10
eLife
● 5828 papers in training set
Top 42%
2.4%
11
Translational Oncology
○ 21 papers in training set
Top 0.3%
1.9%
12
FEBS Open Bio
○ 31 papers in training set
Top 0.2%
1.7%
13
Biochemical and Biophysical Research Communications
○ 84 papers in training set
Top 0.9%
1.7%
14
Cells
○ 249 papers in training set
Top 3%
1.7%
15
Cancer Medicine
○ 26 papers in training set
Top 0.5%
1.7%
16
Aging
○ 75 papers in training set
Top 0.9%
1.5%
17
Pharmaceuticals
○ 34 papers in training set
Top 0.5%
1.5%
18
Molecular Biology Reports
○ 21 papers in training set
Top 0.5%
1.3%
19
Molecules
○ 39 papers in training set
Top 1.0%
1.1%
20
The FASEB Journal
○ 194 papers in training set
Top 4%
1.1%
21
Cellular Signalling
○ 14 papers in training set
Top 0.2%
1.1%
22
International Journal of Molecular Sciences
○ 494 papers in training set
Top 11%
1.1%
23
Frontiers in Pharmacology
○ 111 papers in training set
Top 2%
1.1%
24
ACS Omega
● 105 papers in training set
Top 3%
1.0%
25
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
○ 26 papers in training set
Top 0.6%
1.0%
26
Biomedicines
○ 67 papers in training set
Top 2%
1.0%
27
Neoplasia
○ 23 papers in training set
Top 0.8%
0.9%
28
Molecular and Cellular Biology
○ 47 papers in training set
Top 0.8%
0.9%
29
Cell Death & Disease
147 papers in training set
Top 3%
0.9%
30
Cell Cycle
○ 17 papers in training set
Top 0.4%
0.9%

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.